Hirsutism Not Responding to First-Line Hormonal Contraceptive Therapy in Virilization
This protocol addresses the patient with virilization whose hirsutism has not achieved significant improvement despite a full course of first-line multimodal therapy.
Previous treatment — goal not reached
First-line therapy — a combined hormonal contraceptive (CHC) together with physical or mechanical hair removal and topical eflornithine — did not produce significant improvement in hirsutism (slower, finer regrowth) after at least 6 months. Failure to reach this target is the clinical trigger for escalation.
Next step — partial overview
The approach at this stage involves continuing the combined hormonal contraceptive while augmenting it with an antiandrogen agent. The full structured regimen — including agent selection, monitoring parameters, and the complete management algorithm — is available in the protocol.
Treatment goal
Significant improvement in hirsutism after at least 6 months of medical therapy.
References
DOI: 10.1016/j.jogc.2023.102272
- Antiandrogens can be considered as monotherapy or in addition to combined hormonal contraceptives to enhance efficacy (strong, high).
- For moderate and severe hirsutism, the addition of antiandrogens can enhance the effect of a CHC and should be considered if there is no improvement after 6 months of therapy.
- At least six months of medical therapy is required to see a significant improvement in hirsutism.
View source ↗